Yuanfeng Capital

Lin Haizhuo, the founding partner, leads investment decisions. The investment team operates with a blend of venture investing expertise and operating experience inside Chinese industrial enterprises, which shapes both sourcing and portfolio-company support.

Yuanfeng leverages relationships with large Chinese industrial corporations as a proprietary sourcing channel. Portfolio companies often come through strategic introductions where the corporation sees a technology that can integrate into its supply chain or distribution network, giving Yuanfeng visibility into deals that never reach open auctions.

The firm invests across venture and growth-equity stages in enterprise software, artificial intelligence, healthcare services, and industrial technology. Its mandate spans early-stage technology companies through more mature platforms that can benefit from corporate integration.

Given the firm's strategic-capital model, board representation is common — particularly when the investment includes an active commercial partnership with an industrial corporate. Specific governance terms are negotiated on a deal-by-deal basis and are not publicly disclosed.

Yuanfeng is an independent asset manager, not a captive corporate venture arm. It raises external capital and selects portfolio companies based on financial return potential. The strategic advantage comes from its network of industrial partners, who may co-invest or provide commercial contracts, but the firm retains independent investment discretion.

No. As of mid-2026, Yuanfeng has not publicly disclosed assets under management or total capital deployed. This is consistent with standard practice among many China-based private equity firms that are not required to publicly report fund-level metrics.

The firm's primary geographic focus is mainland China. There is some limited public record of cross-border technology transfer activity, but no dedicated international office or explicit mandate for direct investments outside China has been disclosed.